This content is machine translated Female tumors From the “old-fashioned” CMF to the modern T-DM1 Over the past two decades, the prognosis of breast carcinoma has improved significantly. As a rule, 75% of patients are cured today. The introduction of modern chemotherapeutic agents, particularly taxanes,…
View Post 2 min This content is machine translated Cancer organizations present results of comprehensive evaluation Excellent marks for the promotion of Swiss cancer research The Swiss Cancer Research Foundation and the Swiss Cancer League do an excellent job in promoting Swiss cancer research. They support research projects of excellent quality, resulting in many significant…
View Post 6 min This content is machine translated Actinic keratosis Short treatment duration significantly improves adherence Actinic keratosis (AK) is a premalignant lesion that is common in the fair-skinned population. In the U.S., cryotherapy is most commonly used to address the individual lesions. In addition, other…
View Post 4 min This content is machine translated ESMO Congress Aspirin – a miracle drug in the fight against cancer? Evidence is accumulating that Aspirin® may be effective in cancer prevention, as well as in inhibiting metastases. One of the most renowned researchers and best-known representatives of this new optimism…
View Post 4 min This content is machine translated Multiple Myeloma and MDS Something has happened in therapy The diagnosis and treatment of multiple myeloma (MM) and myelodysplastic syndromes (MDS) have undergone great development in recent years. Modern diagnostic procedures became qualitatively better and more widely available, new…
View Post 4 min This content is machine translated HER2-positive breast cancer and lymphoma New applications and antibodies The antibody-drug conjugate trastuzumab emtansine, T-DM1 (Kadcyla®), is composed of the antibody trastuzumab and the chemotherapeutic agent DM1 and is currently being investigated for the treatment of HER2-positive cancers. It…
View Post 3 min This content is machine translated Highlights from the ASCO Congress New treatment options for melanoma At the ASCO Congress, updates on immunotherapy and kinase inhibitors in melanoma were among the topics presented. Current research is yielding some promising insights into new treatment methods, for example…
View Post 3 min This content is machine translated Actinic keratosis Physicians should reconsider their therapy habits At this year’s Melanoma Congress in Hamburg, the question was raised whether the most commonly used treatment options for actinic keratosis (AK) are the most effective and cost-effective. Furthermore, the…
View Post 2 min This content is machine translated 10 years GIST Group Switzerland GIST – a life with cancer Since 2004, the patient organization “GIST Group Switzerland” (www.gist.ch) has been supporting patients with gastrointestinal stromal tumors (GIST) and their families. This year’s annual meeting offered a special program for…
View Post 2 min This content is machine translated On our own account We stand for topicality Dear readers
View Post 3 min This content is machine translated WCM Congress Basal cell carcinoma – What therapies are available for advanced forms? New avenues in the treatment of basal cell carcinoma (BCC) are being intensively discussed by current researchers. In particular, the functioning and inhibition of the Hedgehog signaling pathway offers an…
